Industry News
Please enjoy the latest industry news aggregated from top Life Sciences sources including STAT news, BioPharma Dive, and EndPoints News.
- Pfizer RSV vaccine wins CDC recommendation for seasonal use only
- CDC advisors recommend Pfizer's maternal RSV vaccine in 11-1 vote
- As Biden plans to ban medical debt from credit scores, advocates press for more change
- Ozempic sales surge could continue into 2024, researchers say
- Genetically altered pig heart transplanted into a human for the second time
- Boehringer Ingelheim, Eli Lilly clinch new FDA approval for blockbuster Jardiance to treat chronic kidney disease
- Senators call on FDA to not risk biasing study findings in favor of opioid use
- Morphic’s stock falls after new data suggest lower-than-expected efficacy for its ulcerative colitis pill
- Dexcom recruits new class of college athletes with type 1 diabetes for NIL sponsorship deals
- FDA advisors unanimously reject Intarcia's embattled type 2 diabetes treatment
- Dana-Farber, Brigham breakup could lead to a ripple effect for CGT clinical trials for cancer
- NYC biotech LB Pharmaceuticals eyes $75M for new take on decades-old schizophrenia drug
- Padcev, Keytruda’s new survival data; Seraxis raises $10M for diabetes cell therapy
- STAT+: Up and down the ladder: The latest comings and goings
- AstraZeneca and Daiichi’s next cancer medicine scores in breast tumors